Kathryn Chapman

4.0k total citations · 1 hit paper
69 papers, 2.6k citations indexed

About

Kathryn Chapman is a scholar working on Molecular Biology, Small Animals and Immunology. According to data from OpenAlex, Kathryn Chapman has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Small Animals and 13 papers in Immunology. Recurrent topics in Kathryn Chapman's work include Animal testing and alternatives (16 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Biosimilars and Bioanalytical Methods (9 papers). Kathryn Chapman is often cited by papers focused on Animal testing and alternatives (16 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Biosimilars and Bioanalytical Methods (9 papers). Kathryn Chapman collaborates with scholars based in United Kingdom, United States and Switzerland. Kathryn Chapman's co-authors include Michael D. Briggs, Michael E. Grant, Geert Mortier, Fiona Sewell, Natalie Burden, Andy Mead, Paul Butler, Eoin C. O’Connor, Karl E. Kadler and Vicky Robinson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Kathryn Chapman

67 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Does age matter? The impact of rodent age on study outcomes

2016 249 citations Kathryn Chapman et al. profile →

Peers

Kathryn Chapman

IMMUN

RHEUM

GENET

A. Conti Italy

Roland R. Tremblay Canada

Dario Greco Finland

Nick Pullen United States

Richard A. Hughes United Kingdom

Mamoru Satoh Japan

Takeshi Kanno Japan

Hong Fang China

Toshihito Tanahashi Japan

Luca Bianchi Italy

A. Conti Italy

Kathryn Chapman

1.3k ×1.6

275 ×0.7

IMMUN

43 ×0.1

191 ×0.6

RHEUM

503 ×1.8

GENET

Citations per year, relative to Kathryn Chapman Kathryn Chapman (= 1×) peers A. Conti

Countries citing papers authored by Kathryn Chapman

Since Specialization

Citations

This map shows the geographic impact of Kathryn Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Chapman more than expected).

Fields of papers citing papers by Kathryn Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Chapman. The network helps show where Kathryn Chapman may publish in the future.

Co-authorship network of co-authors of Kathryn Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Chapman. A scholar is included among the top collaborators of Kathryn Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Chapman. Kathryn Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bythell‐Douglas, Rohan, Sylvie van Twest, Elyse Dunn, et al.. (2025). Structural basis of Fanconi anemia pathway activation by FANCM. The EMBO Journal. 44(14). 4013–4036. 1 indexed citations

Savarese, Marco, Susanne Rinné, Anne Schänzer, et al.. (2023). Differential effects of mutations of POPDC proteins on heteromeric interaction and membrane trafficking. Acta Neuropathologica Communications. 11(1). 4–4. 4 indexed citations

Han, Namshik, Woochang Hwang, Konstantinos Tzelepis, et al.. (2021). Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies. Science Advances. 7(27). 33 indexed citations

Hwang, Woochang, et al.. (2021). Current and prospective computational approaches and challenges for developing COVID-19 vaccines. Advanced Drug Delivery Reviews. 172. 249–274. 32 indexed citations

Golforoush, Pelin, Patricia Cháves, Robert Yan, et al.. (2020). Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4. Scientific Reports. 10(1). 12060–12060. 19 indexed citations

Sillito, Rowland R., Claire Grant, Natasha A. Karp, et al.. (2018). Pharmacological validation of individual animal locomotion, temperature and behavioural analysis in group-housed rats using a novel automated home cage analysis system: A comparison with the modified Irwin test. Journal of Pharmacological and Toxicological Methods. 94(Pt 1). 1–13. 13 indexed citations

Sewell, Fiona, Kathryn Chapman, Jessica A. Couch, et al.. (2017). Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use. mAbs. 9(5). 742–755. 20 indexed citations

Chapman, Kathryn, Paul Baldrick, Antônio da Silva, et al.. (2016). Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges. mAbs. 8(3). 427–435. 28 indexed citations

Ewell, Patrick J., et al.. (2016). Differences in Colorectal Cancer Risk Knowledge Among Alabamians: Screening Implications. Oncology nursing forum. 43(1). 77–85. 2 indexed citations

10.

Burden, Natalie, Kathryn Chapman, Fiona Sewell, & Vicky Robinson. (2015). Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs).. PubMed. 54(2). 198–208. 105 indexed citations

11.

Burden, Natalie, Fiona Sewell, & Kathryn Chapman. (2015). Testing Chemical Safety: What Is Needed to Ensure the Widespread Application of Non-animal Approaches?. PLoS Biology. 13(5). e1002156–e1002156. 40 indexed citations

12.

Chapman, Kathryn, Simon Chivers, David Mitchell, et al.. (2014). Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug Discovery Today. 19(5). 528–532. 56 indexed citations

13.

Chapman, Kathryn, Fiona Sewell, Matthias Festag, et al.. (2013). A global pharmaceutical company initiative: An evidence-based approach to define the upper limit of body weight loss in short term toxicity studies. Regulatory Toxicology and Pharmacology. 67(1). 27–38. 46 indexed citations

14.

Desmond, Renée A., et al.. (2013). Sustainability in a State Comprehensive Cancer Control Coalition: Lessons Learned. Journal of Cancer Education. 29(1). 188–193. 2 indexed citations

15.

Chapman, Kathryn, et al.. (2012). Colorectal Cancer Screening Practices in Alabama: A Survey of Primary Care Physicians. Journal of Cancer Education. 27(4). 687–694. 5 indexed citations

16.

Jenkins, Todd, Kathryn Chapman, Christine S. Ritchie, et al.. (2011). Hospice Use in Alabama, 2002–2005. Journal of Pain and Symptom Management. 41(2). 374–382. 4 indexed citations

17.

Nicholls, Keith W., et al.. (2011). Enhancing Response Rates in Physician Surveys: The Limited Utility of Electronic Options. Health Services Research. 46(5). 1675–1682. 48 indexed citations

18.

Chapman, Kathryn, Nick Pullen, Laura Andrews, & Ian Ragan. (2010). The future of non-human primate use in mAb development. Drug Discovery Today. 15(5-6). 235–242. 21 indexed citations

19.

Robinson, Sally, Matthias Festag, Sophie Kervyn, et al.. (2007). A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development. Regulatory Toxicology and Pharmacology. 50(3). 345–352. 68 indexed citations

20.

Holden, Paul, Roger S. Meadows, Kathryn Chapman, et al.. (2001). Cartilage Oligomeric Matrix Protein Interacts with Type IX Collagen, and Disruptions to These Interactions Identify a Pathogenetic Mechanism in a Bone Dysplasia Family. Journal of Biological Chemistry. 276(8). 6046–6055. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact